The Significance of Aspartate Transaminase and Alanine Transaminase Levels in Diagnosis and Management of Hepatitis Virus-related Liver Diseases with Hepatitis C Patients in Thi-Qar province, Iraq

  • Ahmed Abdulhadi Jabbar 1. Department of Pathological Analysis, College of Applied Medical Sciences, Shatrah University, Thi-Qar, 64001, Iraq
Keywords: Aspartate Transaminase, Alanine Transaminase Enzymes, Hepatitis C and patients

Abstract

The global spread of hepatitis C infection is concerning. Hepatitis C is a liver-damaging viral infection. It is brought on by the hepatitis C virus and, if untreated, can result in cirrhosis, liver damage, and even liver cancer. Contact with contaminated blood, such as sharing needles or getting a blood transfusion, is typically how the virus is transmitted. The infection can be treated with antiviral drugs. Liver cells are the primary location for the enzymes AST (aspartate aminotransferase) and ALT (alanine aminotransferase). A blood test measures two liver enzymes, AST and ALT, to assess the condition of your liver. A liver issue is generally indicated by elevated AST and ALT levels. Healthcare professionals can order additional tests and make an educated guess as to the underlying cause of the liver problem based on which enzyme is elevated or if both are elevated. This could aid in the diagnosis of conditions ranging from liver cancer and liver failure to cirrhosis and hepatitis. The purpose of the current study was to evaluate the association between hepatitis C patients and the liver enzymes aspartate transaminase and alanine transaminase.  Patients serums of 40  HCV positive was taken out and 40 healthy HCV negative as controlling groups  and examined for ALT and AST analytical measurement. Cross-sectional study was directed from December 2022 to March 2023 in  Thi-Qar government, Iraq. Participants age ranged between  ≥15 to ≤ 75 years , AST have increased  levels in HCV patients as compared to ALT as compared with controlling group . study gender-based shows an  increased  level of both the enzymes ALT and AST in females as compared to males .age-based study concluded ALT and AST  have a  non-significant level in age groups  > 49 Years in  HCV patients. Study gender-based shows an increased level of both the enzymes ALT and AST in females as compared to males. Moreover, gender-based study concluded ALT and AST  have a  non-significant level in age groups  > 49 Years in  HCV patients . AST have increased levels in HCV patients as compared to ALT indicating AST to be more specific biomarker of HCV infection and liver damage. The research advised against coming into close touch with blood. Never share anything that could have other people's blood on it, even if it seems clean, to lessen the possibility of blood-to-blood contact. The virus may be present even in a dried patch of blood that is too tiny to be seen.

References

1. Oh RC, Hustead TR, Ali SM, Pantsari MW. Mildly elevated liver transaminase levels: causes and evaluation. Am Fam Physician. 2017;96(11):709–15.
2. Dowsett, L. E., Coward, S., Lorenzetti, D. L., MacKean, G., & Clement, F. (2017). Living with hepatitis C virus: a systematic review and narrative synthesis of qualitative literature. Canadian Journal of Gastroenterology and Hepatology, 2017.‏
3. Law, M. G., Dore, G. J., Bath, N., Thompson, S., Crofts, N., Dolan, K., ... & Wodak, A. (2003). Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. International journal of epidemiology, 32(5), 717-724.‏
4. Centers for Disease Control and Prevention. (2012). Hepatitis C FAQs for health professionals. Centers for Disease Control and Prevention.‏
5. Smith, B. D., Morgan, R. L., Beckett, G. A., Falck-Ytter, Y., Holtzman, D., Teo, C. G., ... & Ward, J. W. (2012). Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. Morbidity and Mortality Weekly Report: Recommendations and Reports, 61(4), 1-32.‏
6. 5-Denniston, M. M., Klevens, R. M., McQuillan, G. M., & Jiles, R. B. (2012). Awareness of infection, knowledge of hepatitis C, and medical follow‐up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001‐2008. Hepatology, 55(6), 1652-1661.‏
7. Daw, M. A., El-Bouzedi, A. A., Ahmed, M. O., Dau, A. A., Agnan, M. M., & Drah, A. M. (2016). Geographic integration of hepatitis C virus: a global threat. World journal of virology, 5(4), 170.‏
8. Markov, P. V., van de Laar, T. J., Thomas, X. V., Aronson, S. J., Weegink, C. J., van den Berk, G. E., ... & Schinkel, J. (2012). Colonial history and contemporary transmission shape the genetic diversity of hepatitis C virus genotype 2 in Amsterdam. Journal of virology, 86(14), 7677-7687.‏
9. Alter, M. J. (2007). Epidemiology of hepatitis C virus infection. World journal of gastroenterology: WJG, 13(17), 2436.‏
10. Leon, L., Kasereka, S., Barin, F., Larsen, C., Weill-Barillet, L., Pascal, X., ... & Le Strat, Y. (2017). Age-and time-dependent prevalence and incidence of hepatitis C virus infection in drug users in France, 2004–2011: model-based estimation from two national cross-sectional serosurveys. Epidemiology & Infection, 145(5), 895-907.‏
11. Jhaveri, R., Broder, T., Bhattacharya, D., Peters, M. G., Kim, A. Y., & Jonas, M. M. (2018). Universal screening of pregnant women for hepatitis C: the time is now. Clinical Infectious Diseases, 67(10), 1493-1497.‏
12. European Association for The Study of The Liver. (2018). EASL recommendations on treatment of hepatitis C 2018. Journal of hepatology, 69(2), 461-511
13. WHO: Global health sector strategy on viral hepatitis,2016-2021. Available from https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/..‏
14. Hyder, M. A., Hasan, M., & Mohieldein, A. H. (2013). Comparative levels of ALT, AST, ALP and GGT in liver associated diseases. European journal of experimental biology, 3(2), 280-284.‏
15. Al-Jumaily, E. F. (2012). The effect of chronic liver diseases on some biochemical parameters in patients serum. Current Research Journal of Biological Sciences, 4(5), 638-642.‏
16. Kolodgie, F. D., Burke, A. P., Farb, A., Weber, D. K., Kutys, R., Wight, T. N., & Virmani, R. (2002). Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arteriosclerosis, thrombosis, and vascular biology, 22(10), 1642-1648.
17. Ruggieri, A., Gagliardi, M. C., & Anticoli, S. (2018). Sex-dependent outcome of hepatitis B and C viruses infections: synergy of sex hormones and immune responses?. Frontiers in Immunology, 9, 2302
Published
2025-01-17
How to Cite
Abdulhadi Jabbar, A. (2025). The Significance of Aspartate Transaminase and Alanine Transaminase Levels in Diagnosis and Management of Hepatitis Virus-related Liver Diseases with Hepatitis C Patients in Thi-Qar province, Iraq. Central Asian Journal of Medical and Natural Science, 6(1), 317-325. https://doi.org/10.17605/cajmns.v6i1.2700
Section
Articles